Q&A: MDMA Strikes Optimistic Tone For Coming Year
Mark Leahey, who leads the Medical Device Manufacturers Association, says the group’s member companies are confident about the prospects of policy wins on key issues including the device tax, US FDA review and reimbursement under the Trump administration.
You may also be interested in...
The House Energy and Commerce Committee Democrat says few in-depth member talks about user-fee bills have taken place because of a focus on Affordable Care Act repeal and replacement.
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?